Eng

Nezha Craze Sweeps the City Wai Yuen Tong Proudly Sponsors Broadcast of "Nezha: The Demon Child Comes into the World" on Jade Channel

PR Newswire (美通社)
更新於 02月27日13:00 • 發布於 02月27日12:09 • PR Newswire

HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Hong Kong's traditional Chinese medicine pioneer Wai Yuen Tong (0897.HK) announced its proud sponsorship of the TVB Jade Channel's broadcast of the film " Nezha: The Demon Child Comes into the World " (Nezha 1) on February 28 at 8 PM. This film will provide viewers with an opportunity to revisit the classic and immerse themselves in the current Nezha craze. With the unprecedented success of "Nezha: The Demon Boy Havoc in the Sea" (Nezha 2), which became the first film in mainland cinema history to surpass 10 billion in box office revenue, revisiting "Nezha 1" will allow the audience to gain a deeper understanding of this legendary character and prepare for the upcoming sequel. Wai Yuen Tong hopes to use this sponsorship to convey the wisdom and values of Chinese culture to the younger generation, aligning with its commitment to uphold traditional values.

Strategic Alignment of Sponsorship and Cultural Mission

Wai Yuen Tong has always adhered to its mission of promoting Chinese culture and traditional medicine. Through this sponsorship, we look forward to allowing the audience to gain a deeper understanding of Wai Yuen Tong's brand philosophy while imparting the profound cultural essence of traditional Chinese medicine to the younger generation. As a brand with a century-long heritage in Hong Kong, Wai Yuen Tong sincerely promotes the wisdom of traditional medicine, carefully understanding the health needs of modern individuals, and providing comprehensive and high-quality traditional Chinese medicine products and services, striving to create a new realm of Chinese health care. At the same time, Wai Yuen Tong continuously seeks progress, developing a diverse range of medicinal products to promote the profound essence of traditional Chinese medicine worldwide, in line with the brand's founding purpose.

廣告(請繼續閱讀本文)

Last year, Wai Yuen Tong established the "Guangdong-Hong Kong International Cooperation Base for Traditional Chinese Medicine" with Guangzhou University of Chinese Medicine. This base focuses on cooperation in talent cultivation, medical services, and technological innovation, aiming to further promote the development of traditional Chinese medicine and enhance Wai Yuen Tong's influence on the international stage.

A Century of Heritage: Wai Yuen Tong's Journey of Integrity and Innovation

Wai Yuen Tong has a long-standing reputation built over 128 years. The brand continuously pursues excellence in both Chinese and Western medicinal products and traditional Chinese medicine clinic services. It steadfastly adheres to the spirit of "dedicated to preserving health," achieving outstanding sales results for multiple products, including Wai Yuen Tong "Angong Niuhuang Wan (安宮牛黃丸)", "Young Yum Pill (養陰丸)", "Hou Tsao Powder (猴棗除痰散)" and Madame Pearl's Cough Syrup, all of which have received external recognition for many consecutive years.

廣告(請繼續閱讀本文)

In addition to maintaining product quality, Wai Yuen Tong also keeps pace with the times, addressing public health issues. The company operates over 80 outlets in Hong Kong with registered Chinese medicine practitioners, dedicated to safeguarding public health and providing comprehensive traditional Chinese medicine services and support to every client. We believe that through these efforts, we can better serve society and promote the wisdom and culture of traditional Chinese medicine.

Commitment to Quality as Hong Kong's No. 1 Traditional Chinese Medicine Brand

Wai Yuen Tong has invested nearly HKD 600 million in an advanced and modern factory in Yuen Long Industrial Estate that meets the standards of Good Manufacturing Practice (GMP). This factory adheres to the stringent pharmaceutical standards recognized globally, specifically those of the Pharmaceutical Inspection Co-operation Scheme (PIC/S), ensuring efficient and safe operations. Wai Yuen Tong maintains strict control over product quality, emphasizing functionality, safety, and user convenience, and is committed to promoting the essence of traditional Chinese medicine worldwide. As Hong Kong's No. 1 traditional Chinese medicine brand^, Wai Yuen Tong will continuously strive to provide exceptional traditional Chinese medicine products and services to customers around the globe.

廣告(請繼續閱讀本文)

^ According to a survey conducted by Ipsos in March to April 2023 involving 502 users of traditional Chinese health products in Hong Kong. (Copyright belongs to Ipsos Hong Kong Limited)

About Wai Yuen Tong Medicine Holdings Limited

Wai Yuen Tong Medicine Holdings Limited is listed on the Hong Kong Stock Exchange (stock code: 0897) and primarily engages in the research, processing, and retail of medicines and health products, including five major product lines of traditional Chinese medicine sold under the "Wai Yuen Tong" brand ((proprietary Chinese medicines, dietary supplement, homology of medicine and food, decoction and concentrated granule, and lifestyle products as well as Western medicine, health, and personal care products sold under the"Madame Pearl's" and "Pearl's" brands. The company also provides one-stop traditional Chinese medicine healthcare services. For more information about Wai Yuen Tong, please visit .

查看原始文章

更多 Eng 相關文章

China's first AI-powered self-healing power grid system successfully tested
XINHUA
Xinhua Commentary: China's democracy serves the people, safeguards development
XINHUA
Vlog | Dialogue with NPC deputy: advocating rural education in deep mountains
XINHUA
Xinhua News | UK PM announces new 1.6-bln-pound deal for Ukraine to buy missiles
XINHUA
Oscars 2025: Asian designers behind stunning celebrity red carpet looks
Tatler Hong Kong
HONOR Announces 7 Years of Android OS and Security Updates for the HONOR Magic Series
PR Newswire (美通社)
Brunei records highest economic growth rate since 1999
XINHUA
Addentax Group Corp. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
PR Newswire (美通社)
CBAK Energy to Participate at Upcoming Jefferies 6th Asia Forum in Hong Kong
PR Newswire (美通社)
HONOR Introduced Four AI Technologies at MWC 2025
PR Newswire (美通社)
Oscars 2025: A dazzling display of jewellery from Cartier, De Beers, Bulgari and more
Tatler Hong Kong
Exclusive Markets Opens Dubai Rep. Office and Launches a Special Ramadan Promotion
PR Newswire (美通社)
Fushi Deepens Its Reach across Southeast Asia, Leveraging AI to Drive SaaS Innovation
PR Newswire (美通社)
SunCar Partners with Visa to Empower ICBC Cardholder Benefits in China's Affluent Consumer Market
PR Newswire (美通社)
Milan Fashion Week: Giuseppe Zanotti teases Anson Lo collab for fall-winter 2025 collection
Tatler Hong Kong
Interview: CBA All-Star Weekend honors past while fueling China's basketball future
XINHUA
Edward Lee on ‘Culinary Class Wars’, his struggle with identity and the future of innovation
Tatler Hong Kong
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
PR Newswire (美通社)
Meizu Launch Overseas Flyme AI Ecosystem Strategy
PR Newswire (美通社)
3 mainland university students honored for courage, heroism in Hong Kong
XINHUA
Xinhua Headlines: Europe unveils plan for Ukraine peace deal amid Transatlantic rifts
XINHUA
HONOR Underscores Commitment to Open Collaboration at MWC Barcelona 2025
PR Newswire (美通社)